TP53 and familial pancreatic carcinoma: Another study demonstrated that p53-mediated cellular senescence and senescence-associated secretory phenotype (SASP) of CAFs were associated with the proliferative potential of pancreatic cancer cells (PCs) and that treatment of CAFs with p53 inhibitors significantly inhibited the proliferation of PC cells [55].